The U.S. Food and Drug Administration recently added warnings to the labels of widely used cholesterol drugs called statins, which include Pfizer Inc.’s Lipitor. The new labels warn that the drugs may raise blood sugar levels, could cause memory loss, and may increase the risk of Type II diabetes.
According to a Reuters story, researchers with the University of Massachusetts Medical School in Worchester drew data from the Women’s Health Initiative, which included more than 150,000 diabetes-free women in their 50s, ...
continue reading...